Florence Thibaut

11.9k total citations · 2 hit papers
170 papers, 5.2k citations indexed

About

Florence Thibaut is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Florence Thibaut has authored 170 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Psychiatry and Mental health, 51 papers in Clinical Psychology and 32 papers in Cellular and Molecular Neuroscience. Recurrent topics in Florence Thibaut's work include Schizophrenia research and treatment (41 papers), Bipolar Disorder and Treatment (20 papers) and Sexuality, Behavior, and Technology (18 papers). Florence Thibaut is often cited by papers focused on Schizophrenia research and treatment (41 papers), Bipolar Disorder and Treatment (20 papers) and Sexuality, Behavior, and Technology (18 papers). Florence Thibaut collaborates with scholars based in France, Germany and Brazil. Florence Thibaut's co-authors include Fréderico Duarte Garcia, Peter Falkai, Alkomiet Hasan, Hans‐Jürgen Möller, Jeffrey A. Lieberman, Birte Glenthøj, Thomas Wobrock, Wagner F. Gattaz, Dominique Campion and Patricia J. M. van Wijngaarden-Cremers and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Florence Thibaut

160 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance

2012 426 citations Alkomiet Hasan, Peter Falkai et al. The World Journal of Biological Psychiatry profile →
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects

2012 297 citations Alkomiet Hasan, Peter Falkai et al. The World Journal of Biological Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Florence Thibaut France	39	2.1k	1.5k	972	707	612	170	5.2k
James Schmeidler United States	52	2.9k 1.4×	2.2k 1.5×	1.2k 1.3×	681 1.0×	1.1k 1.7×	193	8.8k
Yen Kuang Yang Taiwan	35	2.0k 1.0×	1.1k 0.7×	933 1.0×	831 1.2×	431 0.7×	286	5.3k
Eugenio Aguglia Italy	41	2.5k 1.2×	1.8k 1.2×	1.1k 1.1×	376 0.5×	358 0.6×	218	6.1k
Annamari Tuulio‐Henriksson Finland	42	2.7k 1.3×	1.5k 1.0×	1.3k 1.3×	419 0.6×	853 1.4×	136	6.2k
Rodrigo A. Bressan Brazil	47	2.8k 1.4×	1.8k 1.2×	1.8k 1.8×	1.2k 1.7×	866 1.4×	379	7.9k
Steven D. Targum United States	36	2.1k 1.0×	1.1k 0.8×	718 0.7×	488 0.7×	393 0.6×	134	5.5k
Mark Hyman Rapaport United States	51	3.2k 1.5×	2.1k 1.4×	1.1k 1.2×	570 0.8×	777 1.3×	194	10.5k
Bernard Sabbe Belgium	46	2.3k 1.1×	1.7k 1.1×	1.8k 1.9×	515 0.7×	385 0.6×	246	6.4k
Reinhard Heun Germany	51	2.6k 1.3×	1.2k 0.8×	1.4k 1.4×	584 0.8×	1.4k 2.3×	214	8.0k
Wolfgang Maier Germany	49	2.3k 1.1×	1.1k 0.7×	1.3k 1.4×	913 1.3×	1.1k 1.8×	172	7.1k

Countries citing papers authored by Florence Thibaut

Since Specialization

Citations

This map shows the geographic impact of Florence Thibaut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florence Thibaut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florence Thibaut more than expected).

Fields of papers citing papers by Florence Thibaut

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florence Thibaut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florence Thibaut. The network helps show where Florence Thibaut may publish in the future.

Co-authorship network of co-authors of Florence Thibaut

This figure shows the co-authorship network connecting the top 25 collaborators of Florence Thibaut. A scholar is included among the top collaborators of Florence Thibaut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florence Thibaut. Florence Thibaut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thibaut, Florence, et al.. (2023). Chemsex: review of the current literature and treatment guidelines. Current Addiction Reports. 10(3). 563–571. 12 indexed citations

ELNahas, Gihan & Florence Thibaut. (2023). Perinatal Psychoactive Substances Use: A Rising Perinatal Mental Health Concern. Journal of Clinical Medicine. 12(6). 2175–2175. 7 indexed citations

Turner, Daniel, Peer Briken, Joshua B. Grubbs, et al.. (2022). The World Federation of Societies of Biological Psychiatry guidelines on the assessment and pharmacological treatment of compulsive sexual behaviour disorder. Dialogues in Clinical Neuroscience. 24(1). 10–69. 40 indexed citations

Fovet, Thomas, et al.. (2020). French forensic mental health system during the COVID-19 pandemic. SHILAP Revista de lepidopterología. 1. 100034–100034. 7 indexed citations

Fovet, Thomas, et al.. (2020). Mental health and the criminal justice system in France: A narrative review. SHILAP Revista de lepidopterología. 1. 100028–100028. 22 indexed citations

Ferreri, Florian, et al.. (2020). Pharmacotherapy of Sexual Addiction. Current Psychiatry Reports. 22(6). 30–30. 20 indexed citations

Andreazza, Ana C., Brisa S. Fernandes, Catherine Toben, et al.. (2019). Guidelines for the standardized collection of blood-based biomarkers in psychiatry: Steps for laboratory validity – a consensus of the Biomarkers Task Force from the WFSBP. The World Journal of Biological Psychiatry. 20(5). 340–351. 18 indexed citations

Hennart, Benjamin, Estelle Houivet, Sylvain Dulaurent, et al.. (2017). Assessment of tobacco, alcohol and cannabinoid metabolites in 645 meconium samples of newborns compared to maternal self-reports. Journal of Psychiatric Research. 90. 86–93. 27 indexed citations

Hasan, Alkomiet, Peter Falkai, Thomas Wobrock, et al.. (2015). World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation. The World Journal of Biological Psychiatry. 16(3). 142–170. 89 indexed citations

10.

Thibaut, Florence, John Bradford, Peer Briken, et al.. (2015). The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the treatment of adolescent sexual offenders with paraphilic disorders. The World Journal of Biological Psychiatry. 17(1). 2–38. 36 indexed citations

11.

Garcia, Fréderico Duarte, et al.. (2013). Pharmacologic Treatment of Sex Offenders With Paraphilic Disorder. Current Psychiatry Reports. 15(5). 356–356. 15 indexed citations

12.

Hasan, Alkomiet, Peter Falkai, Thomas Wobrock, et al.. (2012). World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. The World Journal of Biological Psychiatry. 13(5). 318–378. 426 indexed citations breakdown →

13.

Garcia, Fréderico Duarte, et al.. (2012). Les médicaments antidépresseurs influencent-ils les passages à l’acte auto- et hétéroagressifs ?. La Presse Médicale. 42(6). 968–976. 3 indexed citations

14.

Thomas, Simon H. L., Milou D. Drici, Gillian C. Hall, et al.. (2010). Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP). Acta Psychiatrica Scandinavica. 122(5). 345–355. 45 indexed citations

15.

Robert, Sylvie, et al.. (2009). Prenatal exposure to tobacco and risk for schizophrenia: a retrospective epidemiological study. Comprehensive Psychiatry. 51(2). 106–109. 11 indexed citations

16.

Guillin, Olivier, Caroline Demily, & Florence Thibaut. (2007). Brain‐Derived Neurotrophic Factor in Schizophrenia and Its Relation With Dopamine. International review of neurobiology. 78. 377–395. 46 indexed citations

17.

Ménard, Jean-François, Gabrielle Allio, Sadeq Haouzir, et al.. (2005). P50 inhibitory gating deficit is correlated with the negative symptomatology of schizophrenia. Psychiatry Research. 136(1). 27–34. 54 indexed citations

18.

Brazo, P., Rose Marie, Karim Bénali, et al.. (2002). Cognitive patterns in subtypes of schizophrenia. European Psychiatry. 17(3). 155–162. 88 indexed citations

19.

Thibaut, Florence, Didier Hannequin, Cosette Martin, et al.. (1998). No association of apolipoprotein epsilon 4 allele with schizophrenia even in cognitively impaired patients. Schizophrenia Research. 30(2). 149–153. 22 indexed citations

20.

Campion, Dominique, Thierry d’Amato, Christian Bastard, et al.. (1994). Genetic study of dopamine D1, D2, and D4 receptors in schizophrenia. Psychiatry Research. 51(3). 215–230. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact